SOL (BIT:SOL) Could Be 15% Undervalued On Strong Half Year Earnings

Why SOL (BIT:SOL) is in focus after fresh half year results

SOL (BIT:SOL) is back on investor radar after reporting half year figures to June 30, 2026, with higher sales, revenue and net income compared with the same period a year earlier.

The latest move takes SOL’s share price to €54.9, with a 1-day share price return of 2.81% and a year-to-date share price gain of 14.26%. However, the 90-day share price return declined 9.26%, so recent momentum has cooled even as the 5-year total shareholder return of 189.32% remains very strong.

Scan other high quality operators with similar resilience by checking our hand picked list of 227 resilient stocks with low risk scores alongside SOL’s latest move.

Fresh results, a €54.9 share price and a 14.5% discount to analyst targets put SOL at an interesting crossroads. Is the caution after that 90 day pullback still justified, or is the gap overdone?

Preferred Price-to-Earnings of 28.7x: Is it justified for SOL?

SOL trades at a P/E of 28.7x, which is above several reference points. The current €54.9 share price therefore reflects a rich earnings multiple compared with many alternatives.

The P/E ratio compares what investors are willing to pay today for each euro of current earnings. For a business like SOL, which operates across industrial and healthcare gases as well as related services, this measure often reflects how much the market is willing to pay for the quality and consistency of profits rather than just headline growth.

Based on the data provided, the market is paying a premium for SOL versus both the European Chemicals industry and an estimated fair level for the shares. The stock trades at 28.7x earnings while the sector average is 17.6x, which is a very strong markup. The same ratio also comes in well above an estimated fair P/E of 17.3x.

The gap to the peer average tells a similar story. SOL looks expensive relative to the broader industry at 28.7x, yet it is described as good value against a narrower peer group that trades around 32x. That suggests investors are already paying heavily for earnings compared with the sector overall, even if the shares do not carry the highest premium inside a tighter comparison set.

Explore the SWS fair ratio for SOL.

Result: Price-to-earnings of 28.7x (OVERVALUED)

Still, the recent 90 day share price decline and the premium P/E valuation mean any slip in SOL’s earnings or sector sentiment could quickly affect confidence.

Find out about the key risks to this SOL narrative.

Another View on SOL’s value using the SWS DCF model

The P/E workup paints SOL as expensive, and the SWS DCF model goes even further. On that approach, an estimated future cash flow value of €29.49 sits well below the current €54.9 share price, which points to a stock trading well above that cash based yardstick. That kind of gap raises a different question. Is the market correctly pricing in qualities that a pure cash flow model might not fully capture?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out SOL for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 179 high quality undervalued stocks. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

Next Steps

Mixed signals around SOL’s valuation and recent share price drift make this a moment to check the numbers yourself rather than follow the crowd. To weigh the upside potential against the issues that concern investors, take a look at the 2 key rewards and 1 important warning sign.

Looking for more SOL investment ideas?

If SOL has you rethinking your watchlist, use this moment to line up a few more candidates that match your risk, income and value preferences.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com